{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:13:16Z","timestamp":1787850796134,"version":"build-2784847793"},"reference-count":31,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2018,3,30]],"date-time":"2018-03-30T00:00:00Z","timestamp":1522368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["106-2113-M-007-005"],"award-info":[{"award-number":["106-2113-M-007-005"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>P-113, which was originally derived from the human saliva protein histatin 5, is a histidine-rich antimicrobial peptide with the sequence AKRHHGYKRKFH. P-113 is currently undergoing phase II clinical trial as a pharmaceutical agent to fight against fungal infections in HIV patients with oral candidiasis. Previously, we developed a new procedure for the high-yield expression and purification of hG31P, an analogue and antagonist of human CXCL8. Moreover, we have successfully removed lipopolysaccharide (LPS, endotoxin) associated with hG31P in the expression with Escherichia coli. In this paper, we have used hG31P as a novel fusion protein for the expression and purification of P-113. The purity of the expressed P-113 is more than 95% and the yield is 4 mg P-113 per liter of E. coli cell culture in Luria-Bertani (LB) medium. The antimicrobial activity of the purified P-113 was tested. Furthermore, we used circular dichroism (CD) and nuclear magnetic resonance (NMR) spectroscopy to study the structural properties of P-113. Our results indicate that using hG31P as a fusion protein to obtain large quantities of P-113 is feasible and is easy to scale up for commercial production. An effective way of producing enough P-113 for future clinical studies is evident in this study.<\/jats:p>","DOI":"10.3390\/molecules23040800","type":"journal-article","created":{"date-parts":[[2018,3,30]],"date-time":"2018-03-30T12:43:48Z","timestamp":1522413828000},"page":"800","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["High Level Expression and Purification of the Clinically Active Antimicrobial Peptide P-113 in Escherichia coli"],"prefix":"10.3390","volume":"23","author":[{"given":"Kuang-Ting","family":"Cheng","sequence":"first","affiliation":[{"name":"Institute of Biotechnology and Department of Medical Science, National Tsing Hua University, Hsinchu 300, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Lung","family":"Wu","sequence":"additional","affiliation":[{"name":"Institute of Biotechnology and Department of Medical Science, National Tsing Hua University, Hsinchu 300, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bak-Sau","family":"Yip","sequence":"additional","affiliation":[{"name":"Institute of Biotechnology and Department of Medical Science, National Tsing Hua University, Hsinchu 300, Taiwan"},{"name":"Department of Neurology, National Taiwan University Hospital, Hsinchu 300, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Yuan","family":"Yu","sequence":"additional","affiliation":[{"name":"Institute of Biotechnology and Department of Medical Science, National Tsing Hua University, Hsinchu 300, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsi-Tsung","family":"Cheng","sequence":"additional","affiliation":[{"name":"Institute of Biotechnology and Department of Medical Science, National Tsing Hua University, Hsinchu 300, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Han","family":"Chih","sequence":"additional","affiliation":[{"name":"Institute of Biotechnology and Department of Medical Science, National Tsing Hua University, Hsinchu 300, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jya-Wei","family":"Cheng","sequence":"additional","affiliation":[{"name":"Institute of Biotechnology and Department of Medical Science, National Tsing Hua University, Hsinchu 300, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,3,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D","article-title":"Animal antimicrobial peptides: An overview","volume":"47","author":"Andreu","year":"1998","journal-title":"Biopolymers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/1097-0282(2000)55:1<4::AID-BIP30>3.0.CO;2-M","article-title":"Amphipathic, a-helical antimicrobial peptides","volume":"55","author":"Tossi","year":"2000","journal-title":"Biopolymers"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/415389a","article-title":"Antimicrobial peptides of multicellular organisms","volume":"415","author":"Zasloff","year":"2002","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1128\/AAC.45.5.1367-1373.2001","article-title":"Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5","volume":"45","author":"Rothstein","year":"2001","journal-title":"Antimcrob. Agents Chemother."},{"key":"ref_6","unstructured":"Helmerhorst, E.J., Oppenheim, F.G., Choi, L., Cheng, J.W., and Reiner, N.E. (2007, January 15\u201317). Evaluation of a new host-derived synthetic antifungal peptide (PAC-113) in the treatment of oral candidiasis. Proceedings of the International Meeting on Antimicrobial Chemotherapy in Clinical Practice (ACCP), Poster, Portofino, Italy."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1034\/j.1600-051x.2001.028005404.x","article-title":"Clinical and microbial evaluation of a histatin-containing mouthrinse in humans with experimental gingivitis","volume":"28","author":"Mickels","year":"2001","journal-title":"J. Clin. Periodontol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1034\/j.1600-051X.2002.291201.x","article-title":"Safety and clinical effects of topical histatin gels in humans with experimental gingivitis","volume":"29","author":"Paquette","year":"2002","journal-title":"J. Clin. Periodontol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1034\/j.1600-051x.2002.290212.x","article-title":"Clinical and microbial evaluation of a histatin-containing mouthrinse in humans with experimental gingivitis: A phase-2 multi-center study","volume":"29","author":"Paquette","year":"2002","journal-title":"J. Clin. Periodontol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/1097-0282(2000)55:3<227::AID-BIP50>3.0.CO;2-7","article-title":"Large-Scale Synthesis of Peptides","volume":"55","author":"Andersson","year":"2000","journal-title":"Biopolym. Pept. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pep.2011.08.001","article-title":"Recombinant production of antimicrobial peptides in Escherichia coli: A review","volume":"80","author":"Li","year":"2011","journal-title":"Protein Expr. Purif."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00253-009-2109-2","article-title":"Production of a cytotoxic cationic antibacterial peptide in Escherichia coli using SUMO fusion partner","volume":"84","author":"Li","year":"2009","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1007\/s00253-012-4441-1","article-title":"Molecular cloning and expression of ranalexin, a bioactive antimicrobial peptide from Rana catesbeiana in Escherichia coli and assessments of its biological activities","volume":"97","author":"Aleinein","year":"2013","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1128\/AEM.71.9.5038-5043.2005","article-title":"Facilitation of expression and purification of an antimicrobial peptide by fusion with baculoviral polyhedrin in Escherichia coli","volume":"71","author":"Wei","year":"2005","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1006\/bbrc.1996.0461","article-title":"Production in Escherichia coli of moricin, a novel type antibacterial peptide from the silkworm Bombyx mori","volume":"220","author":"Hara","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1046-5928(02)00595-8","article-title":"EGFP as a fusion partner for the expression and organic extraction of small polypeptides","volume":"27","author":"Skosyrev","year":"2003","journal-title":"Protein Expr. Purif."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1006\/bbrc.1998.8848","article-title":"Determinants of recombinant production of antimicrobial cationic peptides and creation of peptide variants in bacteria","volume":"247","author":"Zhang","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.procbio.2003.07.007","article-title":"Expression and purification of a recombinant buforin derivative from Escherichia coli","volume":"39","author":"Pyo","year":"2004","journal-title":"Process Biochem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00253-011-3863-5","article-title":"Production, purification, and characterization of the cecropin from Plutella xylostella, pxCECA1, using an intein-induced self-cleavable system in Escherichia coli","volume":"94","author":"Wang","year":"2012","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.bbamem.2006.02.003","article-title":"Expression and purification of a recombinant LL-37 from Escherichia coli","volume":"1758","author":"Ramamoorthy","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pep.2004.01.020","article-title":"A novel carrier molecule for high-level expression of peptide antibiotics in Escherichia coli","volume":"36","author":"Rao","year":"2004","journal-title":"Protein Expr. Purif."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s00253-005-0266-5","article-title":"Expression of the cationic antimicrobial peptide lactoferricin fused with the anionic peptide in Escherichia coli","volume":"72","author":"Kim","year":"2006","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"11318","DOI":"10.1021\/jacs.6b06781","article-title":"Overexpression of antimicrobial, anticancer, and transmembrane peptides in Escherichia coli through a calmodulin-peptide fusion system","volume":"138","author":"Ishida","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pep.2008.04.007","article-title":"A new protocol for high-yield purification of recombinant human CXCL8(3-72)K11R\/G31P expressed in Escherichia coli","volume":"61","author":"Cheng","year":"2008","journal-title":"Protein Expr. Purif."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00249-015-1094-x","article-title":"The effect of amidation on the behaviour of antimicrobial peptides","volume":"45","author":"Mura","year":"2016","journal-title":"Eur. Biophys. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/jccs.200900140","article-title":"Solution structure and model membrane interactions of P-113, a clinically active antimicrobial peptide derived from human saliva","volume":"56","author":"Yip","year":"2009","journal-title":"J. Chin. Chem. Soc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nbt.2572","article-title":"Antimicrobial peptides stage a comeback","volume":"31","author":"Fox","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00253-011-3816-z","article-title":"Recombinant expression, purification, and antimicrobial activity of a novel hybrid antimicrobial peptide LFT33","volume":"95","author":"Feng","year":"2012","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1111\/j.1365-2672.2008.04131.x","article-title":"Production of an Arobidopsis halleri foliar defensin in Esherichia coli","volume":"106","author":"Marques","year":"2009","journal-title":"J. Applied Microbiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s10529-011-0687-4","article-title":"Expression and purification of antimicrobial peptide fuforin IIb in Escherichia coli","volume":"33","author":"Wang","year":"2011","journal-title":"Biotechnol. Lett."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/j.1567-1364.2009.00531.x","article-title":"Increased potency of a novel d-b-naphthylalanine-substituted antimicrobial peptide against fluconazole-resistant fungal pathogens","volume":"9","author":"Wang","year":"2009","journal-title":"FEMS Yeast Res."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/23\/4\/800\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:59:07Z","timestamp":1760194747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/23\/4\/800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,30]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4]]}},"alternative-id":["molecules23040800"],"URL":"https:\/\/doi.org\/10.3390\/molecules23040800","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,30]]}}}